FDA Links Deadly Hepatitis Cluster To Popular Supplement

Law360, New York (October 8, 2013, 5:49 PM EDT) -- The U.S. Food and Drug Administration on Tuesday said one Hawaii resident has died and two dozen more have developed nonviral hepatitis after using a popular line of fat-burning dietary supplements produced by USPlabs LLC, which quickly disputed any link between its products and the illnesses.

Overall, 29 people in Hawaii have in recent months come down with acute hepatitis — liver inflammation that is not contagious — that lacks a known cause, the FDA said. Of those, 11 have been hospitalized, two have required liver...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.